Evidence of Increased Inflammation and Microcirculatory Abnormalities in Patients With Type 1 Diabetes and Their Role in Microvascular Complications
- 1 November 2007
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 56 (11), 2790-2796
- https://doi.org/10.2337/db07-0784
Abstract
OBJECTIVE—Type 1 diabetes is associated with increased microvascular complications and inflammation. The monocyte-macrophage is a pivotal cell in atherogenesis. There are scanty data on noninvasive measures of microvascular abnormalities and inflammation in type 1 diabetic subjects with microvascular complications. Thus, we examined systemic and cellular biomarkers of inflammation in type 1 diabetic patients with microvascular complications (T1DM-MV patients) and type 1 diabetic patients without microvascular complications (T1DM patients) compared with matched control subjects and determined the microcirculatory abnormalities in the T1DM and T1DM-MV patients using computer-assisted intravital microscopy (CAIM). RESEARCH DESIGN AND METHODS—Fasting blood, 24-h urine, and CAIM measurements were obtained from the T1DM and T1DM-MV patients and matched control subjects. C-reactive protein, E-selectin, nitrotyrosine, monocyte superoxide, and cytokines were elevated in the T1DM and T1DM-MV patients compared with control subjects (P < 0.01). RESULTS—Severity index, as assessed by CAIM, was significantly increased in the T1DM and T1DM-MV patients compared with the control subjects (P < 0.001). There was a significant increase in C-reactive protein, nitrotyrosine, vascular cell adhesion molecule and monocyte superoxide anion release, and interleukin-1 release in T1DM-MV compared with T1DM patients (P < 0.05). T1DM-MV patients had significantly increased CAIM severity index and microalbumin-to-creatinine ratio compared with T1DM patients (P < 0.05). Furthermore, pp38MAPK, pp65, and pERK activity were significantly increased in monocytes from the T1DM and T1DM-MV patients compared with those from the controls subjects, and pp38MAPK and pp65 activity were significantly increased in the T1DM-MV compared with the T1DM patients (P < 0.01). CONCLUSIONS—T1DM-MV patients have increased inflammation compared with T1DM patients. CAIM provides an effective biomarker of microvascular complications, since it is significantly elevated in T1DM-MV compared with T1DM patients and can be monitored following therapies targeted at improving inflammation and/or microvascular complications of type 1 diabetes.Keywords
This publication has 43 references indexed in Scilit:
- High glucose induces IL-1β expression in human monocytes: mechanistic insightsAmerican Journal of Physiology-Endocrinology and Metabolism, 2007
- Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathyDiabetic Medicine, 2005
- Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes MellitusCirculation, 2005
- Role of Interleukin-1β in the Development of Retinopathy in Rats: Effect of AntioxidantsInvestigative Ophthalmology & Visual Science, 2004
- Role of interleukin-1 in the pathogenesis of diabetic retinopathyBritish Journal of Ophthalmology, 2004
- Elevated Blood Interleukin-6 Levels in Hyperketonemic Type 1 Diabetic Patients and Secretion by Acetoacetate-Treated Cultured U937 MonocytesDiabetes Care, 2003
- Inflammation in atherosclerosisNature, 2002
- Elevated concentrations of circulating adhesion molecules and their association with microvascular complications in insulin-dependent diabetes mellitusJournal of Clinical Endocrinology & Metabolism, 1996
- Soluble forms of intercellular adhesion molecule-1 in insulin-dependent diabetes mellitusThe Lancet, 1994
- Increase in the glucosylated form of erythrocyte Cu-Zn-superoxide dismutase in diabetes and close association of the nonenzymatic glucosylation with the enzyme activityBiochimica et Biophysica Acta (BBA) - General Subjects, 1987